CIRI Opens Coronavirus Clinical Trials

04/09/20 COVID-19 ,   Latest updates

The CHI Institute for Research and Innovation (CIRI) has opened two clinical trials for treatment of patients with COVID-19 at CHI Franciscan St. Joseph Medical Center in Tacoma, WA:

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)
The primary objective of this study is to evaluate the efficacy of two remdesivir (RDV) regimens with respect to the normalization of temperature and oxygen saturation through Day 14 in participants with severe coronavirus disease (COVID-19).

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
The primary objective of this study is to evaluate the efficacy of two remdesivir (RDV) regimens compared to standard of care (SOC), with respect to the time to discharge in participants with moderate coronavirus disease (COVID-19).

For more information, please contact Diana Morales or Conchita Purchase.

CommonSpirit Health Begins Safely Resuming Health Care Services and Procedures MAY 05, 2020

As many states have begun to reopen more business and services, many CommonSpirit Health care sites are safely resuming additional health care services and procedures.

READ MORE
Virtual Support Sessions Help Perinatal Women During Coronavirus Crisis MAY 13, 2020

According to 2020 Mom, up to one in five perinatal women in the U.S. suffers from anxiety or depression, and that’s without the added stress of giving birth during a pandemic. Our Taking Care of Mama program is helping support pregnant women and new moms in these challenging times.

READ MORE
Answering the Call: CommonSpirit Strives to End Health Inequalities MAY 14, 2020

In this Q&A, President and COO Marvin O'Quinn discusses our mission of advancing social justice for all.

READ MORE